CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis

Full target enrollment of 216 patients achieved

Related Keywords

United States ,Rachel Leheny ,Sarah Sutton Kevin Murphy ,Institute For Biomedical Research ,Prnewswire Calcimedica Inc ,Calcimedica Inc ,Chief Executive Officer ,Torrey Pines Therapeutics ,Biomedical Research ,Private Securities Litigation Reform Act ,Annual Report ,Medica Contact ,Region ,